Who may participate

Each clinical study has its own guidelines for who may participate, called eligibility criteria. These factors can include your age, sex, overall health, type and stage of disease, and personal treatment history. However, only the research study staff can determine if you qualify to enroll in the study.

Condition
Obesity and Overweight
Sex
Male or Female
Age
18 - 99 years
Healthy participants
No

Eligibility criteria

Study overview

This study investigates the efficacy and safety of once weekly injectable MET097 in adult participants with obesity or overweight with weight-related comorbidities excluding T2D. This trial will last for a duration of 84 weeks. The primary endpoint will be assessed after 64 weeks of treatment with the secondary at 84 weeks.

View locations for this study

Find the closest location, your results will be shown below
Find the closest location
    Miles
    0500

    Nearest Locations found

    5 sites found

    Research Site 97301-001007

    Riverside, California, United States, 92506
    recruiting status
    Recruiting
    Site Info

    Research Site 97301-001070

    Torrance, California, United States, 90504
    recruiting status
    Recruiting
    Site Info

    Research Site 97301-001077

    Englewood, Colorado, United States, 80113
    recruiting status
    Recruiting
    Site Info

    Research Site 97301-001309

    Cary, North Carolina, United States, 27511
    recruiting status
    Recruiting
    Site Info

    Research Site 97302-001001

    Hollywood, Florida, United States, 33024
    recruiting status
    Recruiting
    Site Info
    • Recruitment Status
    • Site details
    • Study Contact
    • Clinical Trials ID

    Study Locations

    View locations for this studyFind the closest location, your results will be shown belowFind the closest location